Richard Schilsky Bids Adieu to ASCO
email article After close to a decade at the helm, Richard Schilsky, MD, has retired from his role as chief medical officer of the American Society of Clinical Oncology (ASCO). His legacy as the organization's first CMO will be what he calls the "ASCO research enterprise" -- launching ASCO's first-ever clinical trial, increasing its ability to conduct observational studies, and tapping into the 40,000-person membership for original survey-based research. "It was clear that while ASCO was a tremendous vehicle to disseminate and amplify research findings that were generated by various e...